Grifols Plans U.S. IPO for Biopharma Business to Cut Debt and Boost Growth Grifols has approved a U.S. IPO of a minority stake in its Biopharma business. Credit: Angel Garcia/Bloomberg Subscribe now Already have an account? Sign in.
